Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Monday . The company traded as high as $38.88 and last traded at $40.24, with a volume of 196002 shares trading hands. The stock had previously closed at $33.86.
Analysts Set New Price Targets
ZEPP has been the topic of a number of recent research reports. Fundamental Research set a $13.87 price objective on Zepp Health and gave the stock a "buy" rating in a report on Tuesday, April 22nd. Wall Street Zen upgraded Zepp Health to a "hold" rating in a research report on Saturday.
Get Our Latest Analysis on Zepp Health
Zepp Health Stock Performance
The company's fifty day simple moving average is $11.06 and its 200 day simple moving average is $5.67. The stock has a market capitalization of $608.93 million, a P/E ratio of -8.64 and a beta of 1.11. The company has a current ratio of 1.10, a quick ratio of 0.78 and a debt-to-equity ratio of 0.31.
Zepp Health (NYSE:ZEPP - Get Free Report) last issued its quarterly earnings data on Monday, May 19th. The company reported ($1.13) earnings per share (EPS) for the quarter. Zepp Health had a negative return on equity of 24.19% and a negative net margin of 38.81%. The business had revenue of $38.54 million during the quarter.
Zepp Health Company Profile
(
Get Free Report)
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zepp Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.
While Zepp Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.